Failure to Satisfy Listing Rule (Form 8-K)

Item 3.01 - Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

On August 27, 2025, CaliberCos Inc. (the "Company") received written notice from The Nasdaq Stock Market LLC ("Nasdaq") that, based on the Company's stockholders' equity of $(17,604,000) as reported on its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, the Company is no longer in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders' equity for continued listing (the "Stockholder Equity Requirement"). The Nasdaq deficiency letter has no immediate effect on the listing of the Company's Class A common stock. As such, the Company's Class A common stock will continue to trade on The Nasdaq Capital Market under the symbol "CWD".

In accordance with Nasdaq's listing rules, the Company has 45 calendar days to provide a plan to Nasdaq to regain compliance with the Stockholder Equity Requirement. If this plan is accepted by Nasdaq, the Company may be granted an extension of 180 calendar days from receipt of the deficiency letter to evidence compliance. If the Company is granted such extension and does not regain compliance with the Stockholder Equity Requirement by the end of the compliance period, the Company's Class A common stock will become subject to delisting. In the event that the Company receives notice that its Class A common stock are being delisted, the Nasdaq listing rules permit the Company to appeal a delisting determination by the Nasdaq's staff to a Nasdaq hearings panel.

The Company intends to take all reasonable measures available to regain compliance with the Nasdaq listing rules and remain listed on Nasdaq. The Company is currently evaluating various options to regain compliance and plans to timely submit a plan to Nasdaq to regain compliance with the Nasdaq Stockholder Equity Requirement. There can, however, be no assurance that the Company's plan will be accepted by Nasdaq or that, if it is accepted, the Company will be able to regain compliance.